OTC Markets OTCPK - Delayed Quote USD
Cosmo Pharmaceuticals N.V. (CMOPF)
55.00
0.00
(0.00%)
At close: April 25 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
162,411
162,411
22,708
33,226
12,611
Investing Cash Flow
-128,881
-128,881
53,218
1,689
24,857
Financing Cash Flow
-40,224
-40,224
-211,266
-46,133
-27,247
End Cash Position
44,296
44,296
50,275
185,825
198,560
Capital Expenditure
-5,653
-5,653
-4,396
-7,310
-8,504
Issuance of Capital Stock
3,377
3,377
687
270
761
Repayment of Debt
-1,076
-1,076
-176,028
-916
-2,624
Repurchase of Capital Stock
-5,931
-5,931
-12,475
-24,747
-20,506
Free Cash Flow
156,758
156,758
18,312
25,916
4,107
12/31/2021 - 7/31/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OPHLF Ono Pharmaceutical Co., Ltd.
11.81
0.00%
RHHBF Roche Holding AG
349.46
0.00%
NONOF Novo Nordisk A/S
62.25
0.00%
RHHBY Roche Holding AG
39.52
-0.55%
SNY Sanofi
52.32
-2.28%
NVS Novartis AG
112.14
+0.87%
BIIB Biogen Inc.
118.84
-0.56%
OGN Organon & Co.
12.20
+0.66%
GILD Gilead Sciences, Inc.
103.17
-2.81%
BMY Bristol-Myers Squibb Company
47.90
-1.62%